Amgen Sets Up For Independence In Korea
This article was originally published in PharmAsia News
In a sign South Korea is becoming an increasingly important market for multinational biopharma firms, Amgen has set up an independent affiliate in the country. The US biotech giant plans to bring more clinical trials and innovative therapies for serious diseases to a country that it sees as offering medical excellence and a large and diverse patient population.
Register for our free email digests: